| Identification | Back Directory | [Name]
Aminopterin | [CAS]
58602-66-7 | [Synonyms]
Nsc257456
NSC 739 [as the base]
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid disodium salt
L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]amino]benzoyl]-, disodium salt | [Molecular Formula]
C19H21N8NaO5 | [MDL Number]
MFCD00274560 | [MOL File]
58602-66-7.mol | [Molecular Weight]
464.42 |
| Hazard Information | Back Directory | [Uses]
Aminopterin sodium (4-Aminofolic acid sodium) is an anti-tumor drug with immunosuppressive activity. Aminopterin sodium blocks the metabolism of folic acid by inhibiting the activity of dihydrofolate reductase, thereby affecting nucleic acid synthesis. Aminopterin sodium is mainly used to inhibit acute lymphoblastic leukemia and certain other types of cancer. Aminopterin sodium is also used clinically as an immunosuppressant to suppress autoimmune diseases[1]. | [References]
[1] MEYER LM, et al. Aminopterin, a folic acid antagonist, in the treatment of leukemia. Am J Clin Pathol. 1949 Feb;19(2):119-26. DOI:10.1093/ajcp/19.2.119
[2] Aminopterin, a folic acid antagonist, in the treatment of leukemia DOI:10.1093/ajcp/19.2.119
[3] Rosowsky A, et al. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues. J Med Chem. 2004 Dec 30;47(27):6958-63. DOI:10.1021/jm040122s
[4] Gebhardt DO, et al. The influence of aminopterin on limb regeneration in Ambystoma mexicanum. J Embryol Exp Morphol. 1966 Aug;16(1):143-58. PMID:5298244
[5] F. W Gtmrz, et al. THE EFFECT OF 4-AMINO-PTEROYLGLUTAMIC ACID (AMINOPTERIN) ON HUMAN LEUKEMIC LEUKOCYTES IN VITRO. Blood (1950) 5 (2): 161-166. |
|
|